Testing effectiveness (Phase 2)Ended earlyNCT02123966
What this trial is testing
An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Who this might be right for
Chronic Graft-versus-Host-DiseaseOral Mucosal Disease Due to Graft-versus-host Disease
Dana-Farber Cancer Institute 10